咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Enabling personalized medicine... 收藏

Enabling personalized medicine in Europe: a look at the European Commission's funding activities in the field of personalized medicine research

在欧洲的创新的个性化的药: 在欧洲人的看委托在个性化的药研究的领域里资助活动

作     者:Draghia-Akli, Ruxandra 

作者机构:European Commiss Hlth Directorate Directorate Gen Res & Innovat Brussels Belgium 

出 版 物:《PERSONALIZED MEDICINE》 (个性化医疗)

年 卷 期:2012年第9卷第2期

页      面:151-155页

核心收录:

学科分类:1007[医学-药学(可授医学、理学学位)] 10[医学] 

主  题:biomarkers diagnostics education and training enabling technologies EU Horizon 2020 personalized medicine pharmacogenomics rare diseases Seventh Framework Programme 

摘      要:The potential benefits that personalized medicine approaches can bring to healthcare are discussed with much interest throughout the EU. This novel approach is based on a better understanding of the molecular mechanisms of health and disease and it has now begun to show results. There is, however, a long way to go before the area is fully exploited. This special report reviews the European Commission s funding activities related to personalized medicine research. Although the specific focus on personalized medicine is relatively new, the European Commission has already committed significant funding to research in enabling technologies relevant to the field, as well as to specific disease areas for their application. A stocktaking exercise which started in 2010 has helped identify immediate and future challenges in personalized medicine research. The outcome of this exercise, summarized below, will contribute to developing a vision for future research funding at the EU level.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分